Remember That Time Trump Said He “Probably Should” Take Ozempic? (opens in new tab)

A mysterious, well-connected 79-year-old man has gained sole access to an experimental obesity drug created by Eli Lilly.The outlet that first reported the early access, STAT, speculated that the patient could be Donald Trump, in no small part due to the president’s unabashed support for weight-loss drugs, which has extended to suggestions that he and his staff should take what he calls “the fat drug.”In January, the president told The New York Times that while he hadn’t yet taken Ozempic or ...